Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Phenytoin - Generic Drug Details

« Back to Dashboard

What are the generic sources for phenytoin and what is the scope of phenytoin patent protection?

is the generic ingredient in ten branded drugs marketed by Vistapharm, Wockhardt, Taro, Pfizer, Parke Davis, Corepharma, Mylan Pharms Inc, Actavis Mid Atlantic, Warner Chilcott, Marsam Pharms Llc, Fresenius Kabi Usa, Watson Labs, West-ward Pharms Int, Aurobindo Pharma Ltd, Smith And Nephew, Solopak, Sun Pharm Inds (in), Hospira, Sun Pharm Inds, Wockhardt Usa, Ani Pharms Inc, Pharmeral, Parke-davis, Lannett, Amneal Pharms Ny, X-gen Pharms, Luitpold, and Mylan, and is included in forty-one NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for phenytoin. Sixteen suppliers are listed for this compound.

Summary for Generic Name: phenytoin

Drug Master File Entries: see list19
Suppliers / Packagers: see list16
Bulk Api Vendors: see list99
Clinical Trials: see list37
Patent Applications: see list5,048
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:phenytoin at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
phenytoin sodium
CAPSULE;ORAL040298-002Dec 6, 2001ABRXNoNo► Subscribe► Subscribe
Actavis Mid Atlantic
SUSPENSION;ORAL089892-001Sep 25, 1992DISCNNoNo► Subscribe► Subscribe
phenytoin sodium
CAPSULE;ORAL080857-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
SUSPENSION;ORAL040521-001Mar 8, 2004ABRXNoNo► Subscribe► Subscribe
Smith And Nephew
phenytoin sodium
INJECTABLE;INJECTION088519-001Dec 19, 1984DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus